Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
Top Cited Papers
Open Access
- 1 February 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (3) , 381-390
- https://doi.org/10.1086/595830
Abstract
Recombinant adeno-associated viruses (AAVs) have unique gene-transfer properties that speak to their potential as carriers for gene therapy or vaccineKeywords
This publication has 27 references indexed in Scilit:
- A STEP into Darkness or Light?Science, 2008
- Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5Virology, 2006
- Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV VectorsHuman Gene Therapy, 2006
- Novel Caprine Adeno-Associated Virus (AAV) Capsid (AAV-Go.1) Is Closely Related to the Primate AAV-5 and Has Unique Tropism and Neutralization PropertiesJournal of Virology, 2005
- Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid proteinVirology, 2004
- Clades of Adeno-Associated Viruses Are Widely Disseminated in Human TissuesJournal of Virology, 2004
- Infection Efficiency of Human and Mouse Embryonic Stem Cells Using Adenoviral and Adeno-Associated Viral VectorsCloning and Stem Cells, 2003
- Purification of Recombinant Adeno-Associated Virus Vectors by Column Chromatography and Its Performancein VivoHuman Gene Therapy, 2000
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral VectorsHuman Gene Therapy, 1998